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Tomato bushy stunt virus (TBSV), a tombusvirus with a non-segmented, plus-stranded RNA genome, codes for p33 and p92 replicase
proteins. The sequence of p33 overlaps with the N-terminal domain of p92, which also contains the signature motifs of RNA-dependent RNA
polymerases (RdRps) in its non-overlapping C-terminal portion. In this research, we demonstrate in vitro interactions between p33:p33 and
p33:p92 using surface plasmon resonance analysis with purified recombinant p33 and p92. The sequence in p33 involved in the above
protein–protein interactions was mapped to the C-terminal region, which also contains an RNA-binding site. Using the yeast two-hybrid
assay, we confirmed that two short regions within p33 could promote p33:p33 and p33:p92 interactions in vivo. Mutations in either p33 or
p92 within the short regions involved in p33:p33 and p33:p92 interactions decreased the replication of a TBSV defective interfering RNA in
yeast, a model host, supporting the significance of these protein interactions in tombusvirus replication.
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Viral RNA replication requires the assembly of replicase
complexes in infected cells. These replicase complexes,
which are found within characteristic membrane-containing
structures such as multivesicular bodies, are known to
contain the viral RNA template(s) and viral- and host-coded
proteins (Buck, 1996; Noueiry and Ahlquist, 2003). These
factors are likely held together by protein–protein and
protein–RNA interactions within the replicase complex.
For example, the 1a and 2a replicase proteins of Brome
mosaic virus (BMV), which are present within the BMV
replicase, have been demonstrated to interact with each
other using co-immunoprecipitation and the yeast two-
hybrid assays (Kao et al., 1992; O’Reilly et al., 1995,
1997). In addition, 1a is also capable of intermolecular
interaction with other 1a proteins, which might be important
to bring two or more 1a proteins into complex with the 2a
protein (O’Reilly et al., 1998). The relevance of these0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: pdnagy2@uky.edu (P.D. Nagy).intermolecular interactions was confirmed in replication
studies in plant protoplasts using selected BMV mutants
(O’Reilly et al., 1998). Similarly, the 126K protein of
Tobacco mosaic virus (TMV) was shown to form intermo-
lecular interaction with other 126K proteins and with the
186K RNA-dependent RNA polymerase (RdRp) protein
(Goregaoker et al., 2001; Watanabe et al., 1999). Using
temperature-sensitive 126K mutants in the yeast two-hybrid
assay and for replication studies in protoplasts, Goregaoker
et al. (2001) verified that the 126K–186K interaction is
essential for TMV replication. Interestingly, analysis of
purified recombinant 126K-containing complexes by elec-
tron microscopy revealed the formation of ring-like struc-
tures (possibly hexamers), though the function of this
structure is currently unknown (Goregaoker and Culver,
2003). Interaction among various replicase proteins has also
been demonstrated for several other plus-stranded RNA
viruses, including poliovirus (Hope et al., 1997; Lyle et
al., 2002; reviewed by Agol et al., 1999; Racaniello and
Ren, 1996), hepatitis C virus (reviewed by Tellinghuisen
and Rice, 2002), cucumoviruses (Suzuki et al., 2003), and
potyviruses (Schaad et al., 1997).
Tombusviruses, including Tomato bushy stunt virus
(TBSV) and Cucumber necrosis virus (CNV), are posi-
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kb genomic (g)RNA codes for five proteins, of which two,
namely p33 and p92, are essential for replication (Russo et
al., 1994). The signature motifs of RdRp are present in p92
(O’Reilly and Kao, 1998), which is produced via ribosomal
readthrough of the p33 stop codon. It has been estimated
that the amount of p92 in infected cells is about 20-fold
lower than p33 (Scholthof et al., 1995). Both p33 and p92
proteins are present in the highly active purified RdRp
preparation obtained from yeast co-expressing CNV p33
and p92 proteins and DI-72 RNA (Panaviene et al., in
press), suggesting that they might play direct roles in viral
RNA synthesis. In vitro studies with the above CNV RdRp
preparation demonstrated that the CNV RdRp could recog-
nize essential promoter sequences (Panavas et al., 2002),
replication enhancers (Panavas and Nagy, 2003a; Panavas et
al., 2003) and a replication silencer (Pogany et al., 2003)
element during RNA synthesis. The significance of these
cis-acting RNA elements in tombusviruses has been con-
firmed using plant protoplasts (Nicotiana benthamiana and
cucumber) (Fabian et al., 2003; Panavas et al., 2003;
Pogany et al., 2003; Ray and White, 2003) and yeast, a
model host (Panavas and Nagy, 2003b).
The function of p33 is not yet known, although it is
likely involved in RNA replication, because (i) p92 could
not support viral replication in the absence of p33 in plant
protoplasts (Oster et al., 1998; Panaviene et al., 2003) andFig. 1. Schematic representation of the TBSV replicase proteins. (A) The five open
long) are indicated with boxes and the noncoding sequences with solid lines. The
proteins, p33 and p92, are shown schematically. Y represents an amber stop codon
yeast. (B) SDS-PAGE analysis of purified recombinant p33 and p92 proteins and(ii) p33 has been demonstrated to bind to the viral RNA in
vitro (Panaviene et al., 2003; Rajendran and Nagy, 2003).
The RNA-binding region in p33, and the corresponding
overlapping (pre-readthrough) region in p92, has been
mapped to an arginine-proline-rich motif (RPR motif, Fig.
1), which is similar to the RNA-binding sequence of Tat
protein in the Human immunodeficiency virus-1 (Rajendran
and Nagy, 2003). Mutations within the RPR motif in p33
affected gRNA and subgenomic (sg)RNA synthesis (Pan-
aviene et al., 2003) and RNA recombination (Panaviene and
Nagy, 2003), suggesting that p33 is a multifunctional
protein. The RPR motif is also important for the function
of p92 (Panaviene et al., 2003). In addition, the TBSV and
CNV replicase proteins likely bind to intracellular mem-
branes, based on studies with the closely related replicase
proteins of Carnation Italian ringspot virus and Cymbidium
ringspot virus, which have been shown to localize to
multivesicular bodies (membranous structures derived from
peroxisomes or mitochondria) (Burgyan et al., 1996; Rubino
et al., 2001).
Co-purification of p33 and p92 proteins in the RdRp
preparation supported a model that direct interactions
among these proteins might contribute to the stability of
the RdRp complex. To test this hypothesis, in this paper,
we examined if p33 and p92 could interact directly with
each other using surface plasmon resonance (SPR) analyses
with purified recombinant proteins and the yeast two-reading frames coded by the TBSV genomic RNA (approximately 4800 nt
known and predicted functional domains in the two overlapping replicase
-to-tyrosine codon mutation in p92 to facilitate its expression in E. coli and
their derivatives, expressed as MBP fusion proteins in E. coli.
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with p92, and with other p33 molecules (intermolecular
interaction). We identified two short regions within the C-
terminal portion of p33, which promoted the aforemen-
tioned interactions. The significance of p33:p33 and
p33:p92 interactions was confirmed in a model tombusvi-
rus replication system in yeast by expressing p33 and p92
proteins carrying site-specific mutations within the region
needed for protein interaction. Overall, these experiments
supply direct evidence that the TBSV replicase proteins
interact with each other, and that this interaction is impor-
tant for the functions of the replicase proteins during
tombusvirus infection.Results and discussion
Interaction between the recombinant p33 and p92 replicase
proteins in vitro
The TBSV and CNV p33 and p92 replicase proteins are
present in the partially purified RdRp complex, which is
capable of complementary RNA synthesis on added plus- or
minus-stranded TBSV RNA templates (Nagy and Pogany,
2000; Panaviene et al., in press). The RdRp complexmight be
held together by protein–RNA interactions and/or protein–
protein interactions between p33 and p92. To test if interac-
tion between p33 and p92 (p33:p92) or between p33 and p33
(p33:p33) occurs, we used an in vitro protein interaction
assay based on surface plasmon resonance (SPR) measure-Fig. 2. Surface plasmon resonance analysis of interactions among TBSV replicase
in E. coli, were affinity-purified as C-terminal fusions to MBP. The purified MBP-
and p33C (1 AM each) were separately injected in the running buffer over the ch
surface (baseline) to account for bulk effects of running buffer and/or non-specifments. For this assay, we expressed recombinant p33 and p92
proteins in Escherichia coli as fusion proteins to the maltose
binding protein (MBP) as described by Rajendran and Nagy
(2003). The p92 carried a tyrosine codon in place of the p33
stop codon to ensure the expression of the full-length p92
protein in E. coli (Fig. 1A). This tyrosine mutation did not
interfere with the wild-type (wt)-like function of p92 in a two-
component complementation-based system, in which p33
and p92 are expressed from separate TBSV RNAs (Oster et
al., 1998; Panaviene et al., 2003). After affinity purification
of the recombinant p33 and p92 (Fig. 1B, Rajendran and
Nagy, 2003), we carried out SPR measurements with a
Biacore biosensor as described in Materials and methods.
Briefly, the SPR assay provides real-time protein–protein
interaction data (Crouch et al., 1999; Jokiranta et al., 2000),
by measuring the change in refractive index at the surface of
the sensor chip due to change in mass resulting from protein–
protein interaction between the immobilized protein and the
protein that is being passed over the sensor chip. For this
study, we fixed the purified full-length MBP-p33 fusion
protein onto the surface of a CM5 chip using amine-coupling
reaction (Biacore). Then, comparable amounts of purified
recombinant p33, p92, and MBP proteins diluted with the
running buffer were passed separately over the immobilized
MBP-p33 (Fig. 2). As predicted, we obtained strong signals
(between 2000 and 8000 RU, resonance unit) when p33 and
p92 were tested (Fig. 2), demonstrating that both p33 and p92
interacted strongly with the immobilized MBP-p33. In con-
trast, the ‘‘MBP only’’ sample resulted in a signal that was
only slightly above the background (Fig. 2), indicating thatproteins. The p33 and p92 replicase proteins and their derivatives, expressed
p33 was immobilized on CM-5 sensor chip, whereas p33, p92, MBP, p33N,
ip. The interaction data shown were subtracted from the data from control
ic binding.
Fig. 3. Defining interactions among p33:p33 proteins of TBSV in the yeast
two-hybrid assay. The yeast two-hybrid plasmids harboring GAL4
activation (AD) and binding domains (BD) fused to the p33 gene or its
derivatives were co-transformed into AH109 cells. The transformed cells
were serially diluted 10-fold and grown on three different selection media as
shown. Growth on Trp/Leu indicates successful transformation of AH109
cells with plasmids. Growth on Trp/Leu/His and Trp/Leu/His/Ade
indicates transcriptional activation of HIS and ADE marker genes through
interactions between AD and BD fusion proteins. The positive and negative
controls included in the Matchmaker 3 system were used here. Proteins
p33N and p33C represent N- and C-terminal halves of p33 protein (Fig. 1A).
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protein. It is also possible that the weak signal is due to
non-specific binding of MBP to the dextran layer present on
the surface of the sensor chip.
It is important to emphasize that the SPR signal (RU
value) depends not only on the amount (the absolute
number) of interacting molecules, but also on the molecular
weight (MW) of the particular protein. Thus, the higher RU
value for p33:p92 interaction than for p33:p33 interaction
does not necessarily mean that the interaction between p33
and p92 is ‘‘stronger’’ than that between p33 and p33
because p92 has significantly higher MW than p33. In
addition to the above observations, the SPR measurements
also indicate that the binding between p33:p92 or between
p33:p33 is stable (i.e., the dissociation was slow). Overall,
based on the SPR measurements, we propose that the
recombinant p33 can interact stably with other p33 mole-
cules as well as with p92 in vitro.
To test what region in p33 is responsible for protein
binding, we tested the interaction between p33 and two
truncated p33 proteins, termed p33N and p33C (Fig. 1A).
While p33N contains the N-terminal half of p33 with the
putative membrane-spanning domain plus additional N-
terminal sequences, p33C includes the C-terminal half of
p33 with the RNA-binding domain (Fig. 1A). Note that
p33N and p33C do not overlap with each other and they
have similar MW values. The SPR analysis with purified
recombinant proteins demonstrated that p33C could effi-
ciently interact with p33, while the interaction of p33N
with p33 was weak (see comparable RU values for p33N
and MBP-p33) (Fig. 2). Interestingly, the interaction be-
tween p33 and p33C was rather strong (e.g., higher RU
value in spite of the lower MW for p33C than for the full-
length p33) when compared to p33:p33 interaction in spite
of the comparable molar amounts of proteins used in these
assays. This suggests that the C-terminal region in p33
promotes interaction with p33, while the N-terminal hy-
drophobic domain in the full-length p33 may inhibit
p33:p33 interaction. The opposing effects of the N- and
C-terminal domains on p33:p33 interaction might serve as
a regulatory function in vivo, which might affect the
strength (stability) of the p33:p33 interaction. For example,
the inhibitory effect of the N-terminal region of p33 might
be negated when it is buried in membranous structures (due
to the presence of the membrane-spanning domain, Fig.
1A). Thus, the strength of p33:p33 interaction in cells
might depend on the proximity of suitable membranes
interacting with the N-terminal region of p33. Alternative-
ly, it is also possible that the inhibitory effect of the N-
terminal domain in p33 is due to the conditions in the in
vitro assay, which allow the exposure of the hydrophobic
sequences within the N-terminal domain due to the lack of
membranes. Overall, these in vitro SPR experiments con-
firmed that p33 could interact with the C-terminal half of
p33 and possibly with the prereadthrough (overlapping)
sequence in p92.The C-terminal sequence in p33 is essential for p33:p33 and
p33:p92 interactions in the yeast two-hybrid assay
To validate the above in vitro SPR-based observations on
the interactions between p33:p33 and p33:p92, we also
tested the interaction among the TBSV replicase proteins
with the yeast two-hybrid assay (Matchmaker 3, BD Bio-
sciences Clontech). This assay is based on the modular
nature of the GAL4 transcription factor, where the DNA-
binding domain (DB) and the transcription activation do-
main (AD) are fused separately to the test proteins. If there
is interaction among the test proteins, then the BD and AD
domains will be able to activate transcription allowing the
yeast strain to grow on selective media. Using the above
yeast two-hybrid assay, we found that yeast expressing p33
or p33N in any pair-wise combinations, such as p33:p33,
p33:p33N, p33:p33C, p33N:p33N, did not grow on medium
or high stringency media (Fig. 3). In contrast, we did
observe strong positive interaction when p33C was used
in combination with p33C (Fig. 3). Thus, there is some
discrepancy among the SPR measurements and the yeast
two-hybrid data regarding the full-length p33. This might be
due to the presence of the N-proximal hydrophobic mem-
brane-spanning domains in p33 (Fig. 1), which might
interfere with the nuclear localization of the fusion proteins
that is required for detection of positive interactions in the
yeast two-hybrid assay. Accordingly, protein interaction
studies with full-length membrane-associated proteins have
often led to negative results in the yeast two-hybrid assay
(Stagljar and Fields, 2002; Van Aelst et al., 1993). On the
other hand, p33C lacking the membrane-spanning domain
interacted with p33C in the yeast two-hybrid assay (Fig. 3),
as predicted from the in vitro SPR analysis. Overall, the
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firmed that p33C could stably interact with p33C in vivo.
To test if p33C can also interact with the p92 protein in
vivo, we used two truncated p92-derivatives in the yeast
two-hybrid assay. The longer of the two proteins, termed
p33C/92C (Fig. 4), contained the p92 sequence except the
N-terminal membrane-spanning domain (see explanation
above), whereas the shorter protein, termed p92C, contained
only the unique readthrough portion of p92 (Fig. 4). The
yeast two-hybrid test revealed that p33C interacted with
p33C/92C, while it did not interact with p92C (Fig. 4).
Thus, the obtained data suggest that the interaction between
p33 and p92 includes similar sequences with those respon-
sible for intermolecular interaction between p33:p33. In
contrast, the unique readthrough portion of the p92 (i.e.,
p92C, Fig. 1), which contains the RdRp motifs, is unlikely
to interact with p33 in vivo.
In general, the p33:p33 and p33:p92 interaction domains
in TBSV p33 and p92 show similar arrangement to those
found for the distantly related 126K/183K of TMV replicase
proteins, which are also expressed via ribosomal readthrough
mechanism (Buck, 1999). For example, the C-terminal heli-
case-like domain of 126K protein interacted with the
corresponding regions in 126K (intermolecular interaction)
and in 183K, while the readthrough portion of the 183K
protein carrying the RdRp motifs did not participate in this
interaction (Goregaoker and Culver, 2001). Additional sim-
ilarity between the TBSV and TMV replicase proteins is the
presence of an RNA-binding sequence in proximity to the
protein interaction domain (Osman and Buck, 2003). In spite
of the similar arrangement of the above domains, the
replicase proteins of TMV and TBSV likely perform differ-
ent functions as well. For example, 126K might function as
an RNA helicase and a capping enzyme (Merits et al., 1999;
Goregaoker et al., 2003), whereas p33 lacks these motifs.
Taken together the results shown in this paper suggest
that the C-terminal region in p33 and the corresponding
overlapping (pre-readthrough) sequence in p92 carry
domains, which are likely responsible for assembly and/orFig. 4. Interaction between the TBSV p33 and p92 derivatives in yeast. (A) S
derivatives tested in the yeast two-hybrid assay. The positions of the amino acids
obtained in the yeast two-hybrid assay are shown with the specified constructs. Sstability of the replicase complex, while the major function
of the readthrough portion of p92 might be complementary
RNA synthesis.
Defining short amino acid stretches essential for p33:p33
interaction in yeast
To further delineate the sequences essential for the ob-
served p33:p33 and p33:p92 interactions, we made a deletion
library derived from p33C and tested it for interaction with
p33C in the yeast two-hybrid assay (Fig. 5). These experi-
ments revealed that deletion of 26 or 46 amino acids (aa) from
the C-terminus of p33C (in combination with deletion of 13
aa from the N-terminus) did not interfere with interaction
with p33C (see constructs p33181–270 and p33181–250, Fig. 5).
Additional deletions of 10 or 36 aa from the C-terminus
(constructs p33181–240 and p33181–214 Fig. 5) resulted in
weak interaction with p33C on the medium stringency media,
while no interaction was seen on the high stringency media.
Thus, these experiments indicated that there is a 10 aa stretch
in p33, termed site 1 (located between position 240 and 250
in p33) that is essential for p33:p33 interaction.
To test if there is additional sequence in p33, which
might affect p33:p33 interaction, we made a further series of
combined deletions from both the N- and the C-terminus of
p33C, as shown in Fig. 5. When tested in combination with
p33C, we found that constructs that included a 13-amino
acid stretch, termed site 2, between positions 271 and 283
(for example, constructs p33271–290 and p33263–283, Fig. 5)
interacted with p33C, based on yeast growth on both
medium and high stringency media. Overall, these experi-
ments defined that sites 1 and 2 within p33C were essential
for interaction with p33C in vitro.
To confirm that the above two regions (i.e., site 1 and site
2) can independently interact with p33, we expressed p33219–
250 (which includes site 1) and p33251–296 (which includes
site 2) in E. coli as MBP fusion proteins, followed by affinity
purification as described in Materials and methods (Rajen-
dran and Nagy, 2003; Rajendran et al., 2002). Comparablechematic representation of the full-length p92 (p921 – 818) and its deletion
(aa) present in particular p92 derivatives are shown on the right. (B) Data
ee details from the legend in Fig. 3.
Fig. 5. Defining short regions in p33 that promote p33:p33 interaction. (A) Schematic representation of p33 and its deletion derivatives tested in the yeast two-
hybrid assay is shown on the left. The deleted sequences are indicated with solid lines. The two sites (site 1 and site 2) involved in p33:p33 interaction are boxed.
The amino acid positions in particular p33 derivatives are shown in the center, whereas data obtained in the yeast two-hybrid assay with p33C (p33169 – 296) as bait
are shown on the right. See details from the legend in Fig. 3. (B) Biosensor analysis of interactions between p33 and its two deletion derivatives, p33219 – 250
containing interaction site 1 and p33251 – 296 containing interaction site 2. The biosensor experiments were performed as described from the legend in Fig. 2.
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were then used in an SPR analysis when p33 was fixed on the
surface of the chip (see above). These experiments demon-
strated that both truncated p33 proteins interacted efficiently
with p33 in vitro (Fig. 5B). Therefore, we conclude that site 1
and site 2 within p33 can facilitate the interaction with p33
and possibly with p92 in vitro.
The presence of fusion proteins in yeast with no or
reduced growth was detected by immunoblotting with
anti-HA and anti-c-Myc antibodies against hemagglutinin
(HA) and c-Myc epitope tags, which are present in BD and
AD fusion proteins, respectively (BD Biosciences Clon-
tech). This excludes the possibility that the expressed
proteins were unstable in yeast.Albeit site 1 and site 2 in p33 were able to promote
interaction with the C-terminal region of p33 independently
of each other in vitro and in the yeast two-hybrid assay, it is
possible that they are part of a larger p33:p33 and p33:p92
interaction domain. A more detailed structure/function ana-
lysis of p33 will be necessary to identify the entire interac-
tion domain and the critical amino acids within.
An interesting observation from this and earlier works
(Rajendran and Nagy, 2003) is that the protein interaction
and the RNA-binding regions are in close vicinity within the
C-terminal half of p33, and the corresponding sequence in
p92. Thus, it is possible that RNA-binding and p33:p33
interaction might affect each other. Accordingly, we ob-
served cooperative RNA-binding by p33 in vitro (Rajendran
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might stabilize binding of p33 to the viral RNA. The
functional significance of cooperative binding by p33 is
currently not known.
Mutations within interaction site 1 and site 2 of p33 and p92
inhibit replication of the TBSV replicon in yeast
To test if the above defined interaction site 1 and site 2
are important for replication, we took advantage of the
recently developed TBSV DI RNA replicon system in yeast
(Panavas and Nagy, 2003b). The major advantage of this
heterologous replication system for this work is that it
allows the separate expression of the CNV (very closely
related to TBSV, Fig. 6) p33 and p92 proteins from plasmids
together with a TBSV-derived DI RNA replicon (termed DI-
72 RNA), which is expressed from the galactose-inducible
GAL1 promoter (Panavas and Nagy, 2003b). The wt CNV
p33 and p92 can efficiently support replication of DI-72
RNA even after the suppression of yDI-72 RNA transcrip-
tion by glucose (Panavas and Nagy, 2003b). Using the
above yeast-based tombusvirus replicon system, we sepa-
rately mutagenized p33 and p92 proteins within site 1 and
site 2 and tested the abilities of the resulting mutated
proteins to support DI-72 RNA replication in vivo. To this
end, we mutated four separate amino acid residues to
alanines. These include a tyrosine (Y244) and an arginine
(R246) within site 1, and a phenylalanine (F274) and a
tyrosine (Y276) within site 2 (Fig. 6). These residues were
mutated because they are highly conserved in tombusviruses
(Fig. 6), and that protein–protein interfaces can comprise of
aromatic and charged residues surrounded by hydrophobic
residues (Gallet et al., 2000; Ma et al., 2003). When tested
in the two-hybrid assay, Y244-A and R246-A mutations
within site 1 decreased the number of yeast colonies on
high-stringency media, suggesting that these mutations
affected p33:p33 interaction (Fig. 7A). Importantly, Y244-
A and R246-A mutations present in either p33 or p92
supported very low level of DI-72 RNA replication in yeastFig. 6. Sequence alignment of p33:p33/p92 interaction sites in tombus and
related viruses. Interaction sites 1 and 2 are shown with bold-faced letters.
The conserved amino acids selected for mutagenesis in the CNV sequence
are boxed. The following abbreviations were used: TBSV, Tomato bushy
stunt virus (cherry strain, top, and pepper strain, third row); CNV,
Cucumber necrosis virus; AMCV, Artichoke mottled crinkle virus;
CymRSV, Cymbidium ringspot virus; CIRV, Carnation Italian ringspot
virus; MNeSV, Maize necrotic streak virus; and Pothos latent virus (PoLV,
tombusviridae).at 30 jC (Fig. 7B) or 34 jC (not shown). We conclude that
these amino acids are important for the function of both p33
and p92 proteins. Because the mutated p33 proteins were
present in comparable amount with the wt p33 in yeast (Fig.
7, Western), we suggest that the Y244-A and R246-A muta-
tions decreased the strength (stability) of interactions among
the replicase proteins, which might have led to the assembly
of less stable or less active replicase complexes in yeast.
Similar to the site 1 mutants, the site 2 mutants, F274-A and
Y276-A, also affected p33:p33 interaction and replication of
DI-72 RNA in yeast. However, the observed effects were
less pronounced for site 2 mutants than for the site 1 mutants
on p33:p33 interaction in the yeast two-hybrid assay (Fig.
7A) and on DI-72 RNA replication in yeast expressing
either mutated p33 or p92 (Fig. 7B). Overall, these results
support the model that p33:p33 and/or p33:p92 interactions
are essential for tombusvirus replication.
In summary, for the first time we demonstrated direct
interaction among the replicase proteins of a tombusvirus
using an in vitro SPR method with purified recombinant
proteins and in vivo using the yeast two-hybrid assay. The
identified replicase protein interaction domain seems to be
important for replication of a model tombusvirus template,
suggesting that this interaction is essential for the assembly
and/or function of the tombusvirus replicase.Materials and methods
Biosensor assay
The recombinant proteins used for the biosensor assays
were expressed as fusions to MBP in E. coli and purified as
described by Rajendran and Nagy (2003). The surface
plasmon resonance (SPR)-based biosensor assays were
carried out using BIACORE X (Biacore, Inc., Piscataway,
NJ) at 25 jC. The running buffer (10 mM HEPES pH 7.4,
150 mM NaCl, 3 mM EDTA, 0.05% surfactant P-20) and
the protein immobilization buffer (10 mM sodium acetate,
pH 5.0) were filtered and degassed before use. The sensor
chip CM-5 and the amine coupling kit were purchased from
Biacore. The purified recombinant MBP-p33 (see above)
was dialyzed in the immobilization buffer to achieve a net
negative charge to facilitate the coupling reaction and then
immobilized onto CM-5 sensor chip by using the amine-
coupling chemistry as recommended by the manufacturer.
Briefly, the surface of both flow cells on the sensor chip was
activated with a solution containing N-hydroxysuccinimide
and N-ethyl-NV-(dimethylaminopropyl)-carbodimide for 7
min at the rate of 5Al/min. The purified MBP-p33 (100 Ag/
ml) was injected over the chip on flow cell #1 (Fc1) to
immobilize the protein up to 12500 RU, which corresponds
to approximately 12.5 ng/mm2, whereas flow cell #2 (Fc2)
was left as the control surface to account for non-specific
binding and bulk refractive index changes upon injection of
protein samples, as suggested by the manufacturer. Both
Fig. 7. Effect of mutations within p33:p33/p92 interaction sites 1 and 2 on DI RNA replication in yeast. (A) Two-hybrid interactions between TBSV p33C169 –
296 and the mutants (Fig. 6) generated by substituting selected amino acids with alanine in the protein interaction sites. Note that the mutations were introduced
into truncated p33 proteins, either p33241 – 270 or p33271 – 290 as shown. (B) Northern blot analysis of the effects of the above mutations on replication of DI-72
RNA of TBSV. Yeast strain Sc1 was co-transformed with three plasmids coding for full-length wild type and/or full-length mutants of CNV replicase proteins
(p33 and p92) as shown and a plasmid coding for the TBSV DI-72 RNA replicon. The position of the DI-72 RNA in the total RNA isolated from transformed
yeast cells is shown on the right. The ethidium bromide-stained agarose gel with the 18S ribosomal RNA is shown in the middle as loading control. Western
blot analysis of the amount of p33 present in yeast is shown below the agarose gel. The relative level of DI-72 RNA replication in yeast, based on quantification
of the Northern blot using phosphorimager and ImageQuant (v1.2) software from three separate experiments, was plotted in the graph.
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HCl, pH 8.5, for 7 min at 5 Al/min and washed by repeated
injections with the running buffer.
The protein–protein binding reactions were performed
by injecting the purified test proteins (1 AM) that had been
dialyzed in the running buffer, at the flow rate of 20 Al/min
for 3 min followed by 3 min injection of the running buffer
at the same flow rate. The interactions between the immo-
bilized p33 and the tested recombinant proteins were ana-
lyzed in real time through a sensogram (Fig. 2), in which the
resonance units (RU) were plotted as a function of time. All
the data shown in Fig. 2 were corrected based on data
obtained from the control (Fc2).Yeast two-hybrid assay
Yeast two-hybrid experiments were performed using the
Matchmaker 3 two-hybrid system (BD Biosciences Clon-
tech) based on the Yeast Protocol Handbook (BD Bioscien-
ces Clontech). To clone p33 and p92 genes into the yeast
two-hybrid vectors pGADT7 and pGBKT7 (BD Bioscien-
ces-Clontech), we PCR-amplified them using the full-length
T100 (Hearne et al., 1990, supplied by A. White) and
pHS175 clones (Scholthof et al., 1995, supplied by H.
Scholthof), which had the stop codon at the end of the
p33 gene mutated to tyrosine to facilitate the production of
p92 protein. The PCR products were cloned into plasmid
K.S. Rajendran, P.D. Nagy / Virology 326 (2004) 250–261258vectors using EcoRI and BamHI restriction sites. Similar
cloning strategy was used to make a series of deletion
mutants in p33 and p92 with the help of primers listed in
Table 1. The sequences of the primers are described in Table
2. PCR-based mutagenesis was used to create alanine
substitution mutations as described by Rajendran and Nagy
(2003). To make internal deletions, sequences on both sides
of deletions were PCR amplified separately with primers
containing unique restriction sites (we selected the sites in
such a way to keep the original amino acid sequence),Table 1
List of primer pairs used to make constructs described in text
Constructsa Primers
Surface plasmon resonance assay
p33 3/4
p92 3/5
p92C 6/11
p33C 48/10
p33219 – 250 383/91
p33251 – 296 1188/10
Yeast two hybrid assay
p92 473/475
p92C 187/475
p33C/92C 48/475
p33 473/474
p331 – 160 (p33N) 473/620
p33168 – 296 (p33C) 183/474
p33181 – 214 75/1131
p33181 – 240 75/1132
p33181 – 250 75/1187
p33181 – 270 75/1143
p33181 – 296 75/474
p33211 – 240 76/1131
p33211 – 250 76/1187
p33211 – 296 76/474
p33219 – 296 383/474
p33241 – 257 1141/1142
p33241 – 270 1141/1143
p33241 – 296 1141/474
p33251 – 296 1188/474
p33258 – 296 1189/474
p33263 – 283 77/1202
p33271 – 290 1200/1201
p33271 – 296 1200/474
p33241 – 270Y244A 1206/1143
p33241 – 270R246A 1207/1143
p33271 – 290F274A 1203/1201
p33271 – 290Y276A 1204/1201
DI-RNA replication assay in yeast
p33 Y244A 1212/1213
p33 R246A 1214/1215
p33 F274A 1218/1219
p33 Y276A 1220/1221
p92 Y244A 1212/1213
p92 R246A 1214/1215
p92 F274A 1218/1219
p92 Y276A 1220/1221
a Subscript numbers refer to the aminoacids and/or substitutions the
constructs carry.followed by treatment with the appropriate enzymes and
ligation. The ligated products were then re-amplified by
PCR using the end primers containing EcoRI and BamHI
restriction sites. Finally, we cloned the PCR products into
the yeast two-hybrid vectors as described above. All the
clones used for yeast two hybrid assay were confirmed by
sequencing using T7 sequencing primer (Clontech).
Yeast strain AH109 (BD Biosciences Clontech) was co-
transformed with 500 ng of individual plasmids using
polyethylene glycol-lithium acetate (PEG/LiAC) method.
The transformants were cultured on synthetic drop-out
(SD) medium containing 2% (v/v) glucose and all amino
acids except leucine and tryptophan (SD-Leu-Trp) at 30 jC
for 3–4 days as described in the Matchmaker 3 manual. The
positive and negative control transformations were per-
formed with the plasmids supplied by the manufacturer.
Single colonies from each transformant were grown in 2 ml
of SD medium containing 2% (v/v) glucose without leucine
and tryptophan at 30 jC for 24 h (three repeats per each
experiment). The culture densities were normalized with
SD-Leu-Trp, followed by three times 10-fold serial dilution.
Ten microliters of diluted cultures were grown on SD-Lue-
Trp (low stringency), SD-Lue-Trp-His (medium stringency),
and SD-Lue-Trp-His-Ade (high stringency) growth medium
at 30 jC for 3–4 days. Lue, Trp, His, Ade denote amino
acid residues leucine, tryptophan, histidine, and adenine
respectively.
Replication assay for TBSV DI RNA in yeast
The yeast system for replication of DI RNA described by
Panavas and Nagy (2003b) was adopted to study the role of
interactions among replicase proteins (identified in the yeast
two-hybrid assay) in DI RNA replication. Both p33 and p92
proteins were mutated separately at amino acid positions
244, 246, 274, and 276 by substituting alanine for tyrosine,
arginine, phenylalanine, and tyrosine, respectively, using the
Quick Change mutagenesis kit (Stratagene). The obtained
p33 and p92 clones were sequenced using a reverse primer
to 3V end of p33 gene of CNV (5V-GAGCTGCAGC-
TATTTCACACCAAGGGA-3V).
The yeast plasmids expressing wild type and/or mutant
replicase proteins (p33 and p92) were co-transformed with
pYC-DI72 which codes for DI-RNA into yeast strain SC1
using the PEG/LiAc method. The transformants were grown
at 30 jC in SD medium containing 2%(v/v) galactose
without leucine, tryptophan, and uracil (SD-Leu-Trp-Ura).
Individual colonies for each transformant were cultured in
SD-Leu-Trp-Ura broth containing galactose at 24, 30, and
34 jC for 36, 24, and 20 h, respectively. The cells were then
collected by centrifugation at 500  g for 2 min and re-
suspended in the RNA extraction buffer (50 mM sodium
acetate, 10 mM EDTA and 1% SDS) and mixed thoroughly
by vortexing in the presence of 50% water-saturated phenol.
The mixture was then heated to 65 jC for 4 min, placed on
ice for 2 min and centrifuged at 21,000  g for 4 min at
Table 2
List of primers and their sequences used for PCR to generate constructs described in the text
Primer # Nucleotide positionsa Sequenceb
3 169–186 GAGACCATCAAGAGAATG
4 1056–1039 CT(A/T)TTTGACACCCAGGGA
5 2622–2605 TC(A/C)AGCTACGGCGGAGTCGG
6 1057–1075 GGAGGCCTAGTACGTCTAC
10 1056–1039 GCAGTCTAGACTATTTGACACCCAGGGA
11 2622–2605 GCAGTCTAGATCAAGCTACGGCGGAGTC
48 616–632 GAGGAATTCTACGCTACCCTACCTAG
75 706–723 GAGGAATTCTGTCTGGTGGTTGAGCCG
76 796–813 GAGGAATTCACTGGGCGCCCTCGTCGA
77 952–969 GAGGAATTCGATGTCATATTGCCTTTG
183 667–678 GAGGAATTCGCACGAGCACACATGGAG
187 1057–1075 GAGGAATTCGGAGGCCTAGTACGTCTAC
383 820–837 GAGGAATTCTATGCGGCAAAGATCGCA
473 169–186 GAGGAATTCGAGACCATCAAGAGAATG
474 1036–1053 GAGGGATCCCTATTTGACACCCAGGGACTC
475 2602–2619 GAGGGATCCTCAAGCTACGGCGGAGTCGAG
620 628–645 GAGGGATCCCTACGACAGTTTTTCCCTAGG
1131 868–885 GAGGGATCCCTAATTCTCTGGACTGTTCTT
1132 790–807 GAGGGATCCCTAAGGGCGCCCAGTGGACGC
1141 886–906 GCGGAATTCAGACTAATCTACCAGAGGGTG
1142 916–936 GAGGGATCCCTAGACGCAGTCTTTGTCCATGAT
1143 955–975 GAGGGATCCCTAAATAGCCAAAGGCAATATGAC
1187 898–915 GAGGGATCCCTACTCGATCATCACCCTCTG
1188 916–933 GCGGAATTCATCATGGACAAAGACTGC
1189 934–951 GCGGAATTCGTCAGGTATGTTGACAGG
1200 976–993 GCGGAATTCGGATGCTGTTTTGTCTAT
1201 1018–1035 GAGGGATCCCTACTGTGAGCCCCATAGTGC
1202 991–1018 GAGGGATCCCTACTCCACTCCATCCGGATA
1203 976–1002 GCGGAATTCGGATGCTGTGCTGTCTATCCGGATGGA
1204 976–1008 GCGGAATTCGGATGCTGTTTTGTCGCTCCGGATGGAGTGGAG
1206 886–912 GCGGAATTCAGACTAATCGCCCAGAGGGTGATGATC
1207 886–918 GCGGAATTCAGACTAATCTACCAGGCGGTGATGATCGAGATC
1212 866–898c GAGAATAGATTGATAGCCCAGAGAGTGATGATC
1213 866–898c GATCATCACTCTCTGGGCTATCAATCTATTCTC
1214 872–904c AGATTGATATACCAGGCAGTGATGATCGAGATC
1215 872–904c GATCTCGATCATCACTGCCTGGTATATCAATCT
1218 956–988c GCTATTGGATGCTGCGCTGTCTACCCGGATGGA
1219 956–988c TCCATCCGGGTAGACAGCGCAGCATCCAATAGC
1220 962–994c GGATGCTGCTTTGTCGCCCCGGATGGAGTGGAG
1221 962–994c CTCCACTCCATCCGGGGCGACAAAGCAGCATCC
a Nucleotide positions relative to complete sequence of TBSV genome.
b The italicized nucleotide sequences are mutated to generate alanine substitutions.
c CNV genome.
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two volumes of 95% ethanol and 0.1 volume of 3M sodium
acetate pH 5.2. After 30 min at 20 jC, the RNA was
pelleted by centrifugation at 21,000  g and washed with
70% ethanol for 5 min at 21,000  g at 4 jC. The RNA
pellet was air-dried and resuspended in sterile water. The
RNA was then electrophoresed in 1.5% agarose gel and
transferred onto Hybond-XL membrane (Amersham) using
a semi-dry transblot apparatus (BioRad) (Panaviene et al.,
2003). The membrane was then treated with 2 SSC for 3
min, air-dried, and UV-cross-linked using a crosslinker
(Stratagene). The membrane was then probed with DI
RNA-specific riboprobes, exposed to a phosphorscreen,
and analyzed using a phosphorimager (Molecular Dynam-
ics) as described by Panaviene et al. (2003).Preparation of crude protein extracts from yeast,
SDS-polyacrylamide gel electrophoresis, Western blotting
and immunodetection
Crude protein extracts from yeast were obtained as
described by Kushnirov (2000). Briefly, transformed SC1
yeast strains were grown in 2 ml of SD-Leu-Trp-Ura broth
containing 2% galactose at 30 jC for 24 h. The cells were
then harvested and resuspended in 100 Al sterile water. The
cells were treated with 100 Al 0.2M NaOH at room
temperature for 5 min, followed by a quick spin to remove
the aqueous phase containing the alkali. The pellet was then
resuspended in 50 Al 1 SDS-PAGE loading buffer and the
samples were boiled for 5 min. The cell debris was cleared
by a quick spin and 6 Al of the supernatant was run in 8%
K.S. Rajendran, P.D. Nagy / Virology 326 (2004) 250–261260SDS-PAGE gel. The protein samples were then transferred
from the gel onto PVDF membrane (Biorad). Immunode-
tection of p33 protein in the above samples was performed
by using Anti-His monoclonal antibodies (Amersham)
against the 6 His-tag present at the N-terminus of the
p33 protein (Panaviene et al., 2004).Acknowledgments
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